Combined proton and #chemotherapy boosts stage III #lungcancer survival from 16mo to 26mo, 5 year survival of 29%… https://t.co/gspGNcu31e
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/888336350616977408
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
by Sofie V. Nielsen, Amelie Stein, Alexander B. Dinitzen, Elena Papaleo, Michael H. Tatham, Esben G. Poulsen, Maher M. Kassem, Lene J. Rasm...
-
Abstract RNA degradation is a major problem in tissue banking. We explored the effect of thawing flash-frozen biospecimens on the quality a...
-
Abstract Purpose In targeted radionuclide therapy (TRT), a prior knowledge of the absorbed dose biodistribution is essential for pre-the...
-
From Italian : Pedro and Domenico jump, but Oreste thinks about it a bit... and finds another solution. #donkey #problemsolving Posted a...
-
In metabolomics, thousands of substances can be detected in a single assay. This capacity motivates the development of metabolomics testing,...
-
http://ift.tt/2ukCAsE
-
An Essay Writing Service You Can Trust. By choosing you guarantee that you’ll get a high quality, unique and 100% plagiarism-free essay deli...
-
Volume 72, Issue 1 In this issue Article Brief Communications Correspondence Index Also new AOP ARTICLE Isolation an...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου